期刊文献+

立体定向毁损术治疗难治性精神分裂症的随访研究 被引量:2

A prospective follow up study of therapeutics effect on intractable schizophrenia by stereotactic technique
下载PDF
导出
摘要 目的探讨立体定向毁损杏仁核不同亚核团和扣带回治疗难治性精神分裂症的可行性和疗效.方法对32例难治性精神分裂症患者,采用CRW立体定向仪和CT定位,用Radonics毁损仪毁损杏仁核不同亚核团和扣带回前部,采用临床疗效总评量表(CGI)、简明精神病量表(BPRS)和阳性与阴性症状量表(PANSS)和韦氏智力量表(WISC)等评定疗效,并进行1年的随访.结果显效20例,有效11例,无变化1例;术后BPRS和PANSS量表总分及各项因子分,比术前明显降低(t=6.36~15.96,均P<0.01);韦氏智力测定总智商术后评分[(92.58±17.21)分]与术前评分[(90.61±16.52)分]比较,差异无显著性(t=0.54,P>0.05).结论根据核心症状有选择地毁损杏仁核不同亚核团和扣带回,有助于提高难治性精神分裂症的手术效果. Objective To investigate feasibility and effect of schizophrenia treatment by destroy different subnucleues of amygdale and front part of eallosal gyrus with stereotactic technique. Methods CRW stereo tactic apparatus and CT were used to define nucleus location and Radonics radiofrequeney instruments were used to lesion different subneucleus of amygdale and the front part of callosal gyrus. All schizophrenic patients were diagnosed by CCMD-3 standards. All cases with one year follow up, the effect were analysed with Clinical Global Impression (CGI) , the Brief Psychiatric Rating Scale (BPRS) ,and Positive and Negative Syndrome Scale (PANSS). Results 20 cases were significantly improved, 11 cases improved, 1 case unchanged. There was significantly difference in the marks of PANSS and BPRS before and after stereotaetie technique ( P 〈 0.01 ). There was no difference in intellect of patients with refractor' psychosis before and after stereotaetic technique ( P 〉 0.05 ). Conclusion These results suggest selective destroying subnucleus of arnygdale according to different symptoms of schizophrenia could improve the curative effect of surgical treatment for schizophrenia.
机构地区 解放军第 解放军第
出处 《中国行为医学科学》 CSCD 2005年第10期914-916,共3页 Chinese Journal of Behavioral Medical Science
  • 相关文献

参考文献9

  • 1龚耀先.中国修订韦氏成人智力量表手册[M].湖南地图出版社,1992..
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].济南:山东科学技术出版社,2001.83-90.
  • 3张作记.行为医学量表手册[J].中国行为医学科学,2001,:118-119.
  • 4张明园.精神科评定量表手册[M].长沙:湖南科学技术出版社,1995.151-154.
  • 5Byrum J, Ahearn EP, Krishnan KR. A neuroanatomic modle for depression. Prog Neuropsychopharmacol Biol Psychiatry, 1999, 23: 175.
  • 6Sibley DR, Monsma FJ. Molecular biology of dopamine receptors.TIPS, 1992, 13: 61.
  • 7Kosmal A, Malinowska M, Kowalska DM. Thalamic and amygdaliod connections of the auditory association cortex of the supweior temporal gyrus in rhesus monkey (Macaca mulatta ). Acta Neurobiol Exp (Warsz), 1997, 57: 165.
  • 8Kantak KM, Green-Jordan K, Valencia E et al. Cognitive task performance after lidocaine-induced inactivation of different sites within the basolateral amygdala and dorsal striatum. Behav Neurosci, 2001, 115:589.
  • 9Roesler R, Roozendaal B, McGaugh JL. Basolateral amygdala lesions block the memory-enhancing effect of 8-Br-cAMP infused into the entorhinal cortex of rats after training. Eur J Neurosci, 2002, 15: 905.

共引文献1036

同被引文献32

  • 1王连仲,尹忠民,江晓莲,闻华,王磊,陈实,王金刚,李连祥.立体定向同期多靶点手术治疗难治性精神分裂症392例[J].中华神经外科杂志,2005,21(10):625-629. 被引量:29
  • 2Kopell BH,Rezai AR. Psychiatric neurosurgery: a his-torical perspective[J]. Neurosurg Clin N Am,2003,14(2):181-197.
  • 3Loo C,Katalinic N, Mtchell PB,et aL Physical treatmentsfor bipolar disorder: a review of electroconvulsive therapy,stereotactic surgery and other brain stimulation tecbniques[J].Journal of Affective Disorders, 2011,32(1-2) :1-13.
  • 4Hurd YL. Subjects with major depression or bipolar dis-order show reduction of prodynorphin mRNA expressionin discrete nuclei of the amygdaloid complex [J]. MolPsychiatry,2002,7(1):75 -81.
  • 5Carletti R, Corsi M,Melotto S,et al. Down— regulation ofamygdala preprotachykinin A mRNA but not 3H—SP recep-tor binding sites in subjects affected by mood disorders andschizophrenia[J]. Eur J Neurosci,2005,21(6) :1712-1718.
  • 6Van Sant SP,Buckley PF. Pharmacotherapy for treatment-refractory schizophrenia[J].Expert Opinion on Pharmacotherapy,2011,(03):411-434.
  • 7Quintero J,Barbudo del Cura E,Lopez-Ibor MI. The evolving concept of treatment-resistant schizophrenia[J].Actas Espa olas de Psiquiatría:ACEPSI,2011,(04):236-250.
  • 8El-Badri S,Mellsop G. Clozapine use and outcomes among patients with treatment resistant schizophrenia[J].Australas Psychiatry,2011,(05):410-414.
  • 9Lindenmayer JP,Citrome L,Khan A. A randomized,double-blind,parallel-group,fixed-dose,clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder[J].Journal of Clinical Psychopharmacology,2011,(02):160-168.
  • 10Boggs DL,Nelson MW,Yu Y. Quetiapine at high doses for the treatment of refractory schizophrenia[J].Schizophrenia Research,2008.347-348.

引证文献2

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部